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Here, we describe a nondestructive approach using terahertz wave to detect crack initiation in a ﬁlm-
coated layer on a drug tablet. During scale-up and scale-down of the ﬁlm coating process, differences in
ﬁlm density and gaps between the ﬁlm-coated layer and the uncoated tablet were generated due to
differences in ﬁlm coating process parameters, such as the tablet-ﬁlling rate in the coating machine,
spray pressure, and gas–liquid ratio etc. Tablets using the PEO/PEG formulation were employed as
uncoated tablets. We found that heat and humidity caused tablets to swell, thereby breaking the ﬁlm-
coated layer. Using our novel approach with terahertz wave nondestructively detect ﬁlm surface
density (FSD) and interface density differences (IDDs) between the ﬁlm-coated layer and an uncoated
tablet. We also found that a reduced FSD and IDD between the ﬁlm-coated layer and uncoated tablet
increased the risk of crack initiation in the ﬁlm-coated layer, thereby enabling us to nondestructively
predict initiation of cracks in the ﬁlm-coated layer. Using this method, crack initiation can be
nondestructively assessed in swelling tablets after the ﬁlm coating process without conducting
accelerated stability tests, and ﬁlm coating process parameters during scale-up and scale-down studies
can be appropriately established.
& 2012 Elsevier B.V. All rights reserved.1. Introduction
Process analytical technology (PAT) is a system for designing,
analyzing, and controlling the manufacture of pharmaceutical
compounds through timely measurements (i.e. during processing)
of critical quality and performance attributes of raw and in-
process materials and processes, with the goal of ensuring ﬁnal
product quality. The United States Food and Drug Administration
(FDA) asserts that PAT can reduce production cycle times via on-,
in-, and at-line measurements and controls, thereby preventing
rejects, scrapping, and re-processing; facilitating real time
release; increasing automation to improve operator safety and
reduce human error; improving energy and material use; and
increasing capacity and facilitating continuous processing to
improve efﬁciency and manage variability [3].ll rights reserved.
h & Technology Laboratories,
an. Tel.: þ81 54 627 7958;
(W. Momose).The International Conference on Harmonization (ICH) has
stated that providing ﬂexibility for future process improvement
will beneﬁt from developing measurement systems that allow for
monitoring of critical attributes or process end-points when
describing the development of the manufacturing process [5].
The ICH then goes on to state that collection of process monitor-
ing data during development of the manufacturing process for
new pharmaceutical drugs can provide useful information to
enhance process understanding [5]. In addition, an effective
quality risk management approach can further ensure high
quality of the drug (medicinal) product by providing a proactive
means to identify and control potential quality issues during
development and manufacturing [6]. Further, the ICH requires
that pharmaceutical companies plan and execute a system for
monitoring process performance and product quality to ensure
that control is maintained [7].
The FDA describes PAT as a more advanced technology for
quality by design (QbD), accomplishing continuous improvement
using timely analysis and control loops to adjust the processing
conditions and maintain constant output [4]. A number of pub-
lications have reported on the merits of using near-infrared
W. Momose et al. / Results in Pharma Sciences 2 (2012) 29–3730spectroscopy (NIRS) as a nondestructive PAT tool for in-line
quality monitoring during wet granulation [8,9,27], the blending
process [21,25,33], and at-line quality monitoring of non-coated
tablets [1,16,24]. NIRS is also an effective PAT analyzer in
estimating product quality, as this method requires no pretreat-
ment of samples and provides speedy detection, low damage to
samples, and is nondestructive.
Recently, terahertz technology including both spectroscopy
and imaging has also been used in drug research, in capacities
such as detecting crystal transition rate, assessing polymorphic
content, and in structural analysis of compounds
[14,18,26,28–30]. Several authors have described the beneﬁts of
using terahertz spectroscopy over NIRS [2,22]. One particularly
useful application of terahertz technology as a PAT tool is in end-
point detection in the ﬁlm coating process [23]. Indeed, terahertz
spectroscopy is more effective at detecting coating thickness
directly, without preparing for calibration models using weight
gains, than NIRS. NIRS calibration model detecting end-point of
coating is created by using a correlation between NIR absorption
and the amount of coating materials. If coating process would like
to be stopped at the targeted coating thickness, NIRS is not an
adequate PAT tool because NIR absorption relates to the amount
of coated materials. Coating thickness often dominates properties
of pharmaceutical products more than the amount of coated
materials. Also, NIRS is affected by physical properties of analyte.
One of the beneﬁts using terahertz wave is the principle of the
measurement. Using the index of refraction for analyte is a unique
technology compared with other PAT analyzers. Terahertz tech-
nology is not affected by physical properties of analyte because
the terahertz pulse goes straight in analyte with little diffusion.
Terahertz technology also has been used to nondestructively
predict dissolution properties for tablets and pellets [10–13].
Additionally, the valuable application studies of terahertz spec-
troscopy for pharmaceutical compounds and tablets with chemo
metrics have also been reported [31,32].
There are tablets using swelling polymers including PEO/PEG
formulation [17,19]. Swelling check has been conducted by
appearance check visually. Recently, ultra sounds techniques have
also been used to monitor swelling of hydrophilic polymer matrix
tablets [20].
Here, we explored a novel and a new approach using terahertz
technology as a PAT tool to nondestructively predict crack
initiation in the ﬁlm-coated layer of swelling tablets.Table 2
Typical manufacturing conditions and quality of ﬁlm-coated tablets.
Batch Uncoated
tablet
Coating
Base Weight (mg
X6-1 A Opadry Red 10.2
X6-2 Opadry Red
X6-3 Opadry Red
Z6-1 Opadry Red
Y9-1 B Opadry Orange 11.7
W9-1 Opadry Orange
Table 1
Characteristics of manufactured uncoated tablets.
Batch Uncoated tablet Diameter (mm) Thickness (mm) Weight (mg)
X6 A 9.1 5.4–5.5 341.6
Y9 B 6.0–6.1 391.62. Materials and methods
2.1. Materials
Opadry red and opadry orange were purchased from Colorcon
Inc. (Harleysville, PA, USA). Film-coated tablets prepared by
Astellas Pharma. Inc. (Tokyo, Japan) were used for this study.
Two batches of uncoated tablets were prepared with a 50-mg
difference in total weight between them. In addition, these
uncoated tablets contained expandable excipients.
2.2. Manufacture of ﬁlm-coated tablets
Table 1 summarizes the characteristics of the manufactured
uncoated tablets, while Table 2 shows typical manufacture con-
ditions for the ﬁlm-coated tablets and the rate of crack initiation
(RCI) in the high-temperature degradation test. Calculation of RCI
was conducted by using 10 tablets for each batch.
RCI¼ The number of cracked tablets=10 100 ð1Þ
Six batches of ﬁlm-coated tablets using different coating
materials, production scales, and spray mist diameters were
manufactured. After ﬁlm coating process, tablets were taken from
a coating pan and stored in a drying oven (DO-450VC; AS ONE).
While no cracks were noted under high-temperature conditions
for three of the batches, cracks were observed in the side surface
of ﬁlm-coated tablets in the other three batches, at a ratio of
40–80% of tablets in each affected batch. Images of ﬁlm-coated
tablets stored in the drying oven at 70 1C for 1 h are shown in
Fig. 1. Also, high-temperature degradation tests using the drying
oven (at 60 1C or 70 1C) were conducted in order to evaluate a
crack initiation of ﬁlm-coated tablets with different FSD and IDDs.
After several degradation tests at 70 1C, we reduced the oven
temperature from 70 1C to 60 1C, because we found that the
milder conditions at 60 1C were believed to be better for detecting
differences in sample appearance than those at 70 1C.
2.3. THz wave measurement (instrumentation and data analysis)
Tablets were subjected to terahertz wave measurement using
a TAS7000 (Advantest, Tokyo, Japan). The optical system of theManufacturing
scale
Size of spray mist Rate of crack
initiation (%)
)
Pilot Standard 0
Pilot Large 80
Pilot Small 0
Commercial Standard 40
Pilot Standard 0
Commercial Standard 40
Fig. 1. Film-coated tablets stored in a high-temperature oven (60 min at 70 1C)
(a) without a crack and (b) with a crack.
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Fig. 2. Block diagram of the terahertz wave measurement system TAS7000 and schematic optical system for reﬂection measurement of ﬁlm-coated tablets.
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Fig. 3. Terahertz reference signal. eref(t) (green signal) and measurement signal
esam(t) (blue signal). (For interpretation of the references to color in this ﬁgure
legend, the reader is referred to the web version of this article.)
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reﬂection measurement of tablets. Details of the TAS7000 and
element technologies have already been reported [15]. Brieﬂy, an
ultrashort light pulse (durationo90 fs) emitted from one of the
two ultrashort ﬁber lasers is incident on the photoconductive
switch (PCS) for excitation (Fig. 2). The PCS has a dipole antenna,
to which a bias is applied, patterned on a semiconducting
substrate with a low-temperature-grown GaAs layer. When the
ultrashort light pulse illuminates the gap in the dipole antenna of
the PCS, electric current ﬂows in the gap for a fraction of a second,
and an electromagnetic pulse is emitted.
In addition, another PCS of the same structure is used to detect
terahertz waves. When an ultrashort light pulse is irradiated from
the other ultrashort ﬁber lasers whenever a terahertz wave enters
the ﬁeld, electric current ﬂows through the antenna for a split
second in proportion to the electric ﬁeld of the terahertz wave.
The terahertz wave is then detected based on the presence of the
electric current. Accurately controlling the timing for transmitting
the ultrashort laser pulses to the respective PCSs, the time domain
waveform of terahertz waves can be acquired through detecting
the electric ﬁeld of terahertz waves. In addition, the power
spectrum of the frequency domain through a fast Fourier trans-
form (FFT) can be obtained from the time domain waveform,
thereby allowing spectrometry to be performed. The measure-
ment frequency range of this system is up to 3 THz and the
dynamic range is more than 50 dB.
In the present study, terahertz waves were irradiated onto a
predeﬁned point on a ﬁlm-coated or uncoated tablet (peak of the
curved surface of the tablet; Fig. 2). The time domain waveform of
the mirror-reﬂected terahertz wave was then analyzed. A
reﬂected wave was acquired as a reference waveform by con-
ducting this process using a metal mirror instead of a tablet.
An example of time domain terahertz-wave signals reﬂected
back from the metal mirror and a ﬁlm-coated tablet is shown in
Fig. 3. The reference signal eref(t) and the measurement signal
esam(t) denote reﬂection signals from the metal mirror and ﬁlm-
coated tablet, respectively. Each signal is normalized to the
maximum reference signal. The origin of the horizontal axis
corresponds to the surfaces of the metal mirror and ﬁlm-coated
tablet. For the ﬁlm-coated tablet, the positive portion of the
horizontal axis shows the time delay containing the information
on the internal structure and material properties.
At the origin in Fig. 3, the amplitude of the reference signal
eref(t) is given by I0, and the amplitude of the measurement signal
esam(t) is given by I1. The reﬂectance R1 of a ﬁlm-coated or
uncoated tablet is obtained from the ratio of these amplitudes:
R1 ¼ I1=I0 ð2ÞWhen an electromagnetic wave is incident on interfaces
(material to be measured) with different refractive indices, the
reﬂectance is obtained using Fresnel’s formula. When p-polarized
light is incident on the plane, the reﬂectance R1 can be expressed
as follows:
R1 ¼
n1 cosan0 cosb
n1 cosaþn0 cosb
ð3Þ
Here, n0 is the refractive index (approximately 1.0) of the medium
in which the object to be measured is placed, and n1 is the
refractive index of the surface of the object to be measured. a is
the incidence angle of the electromagnetic wave on the object to
be measured, and b is the diffraction angle of the electromagnetic
wave transmitted into the inside of the object to be measured.
The reﬂectance R1 is known to change depending on the refractive
index of the surface of the object to be measured (ﬁlm-coated or
uncoated tablet), which can be regarded as a parameter repre-
senting the density of the material. Therefore, we can nondes-
tructively and quantitatively determine the density by measuring
the reﬂection of a tablet using terahertz waves. The reﬂectance R1
can also be termed as the ‘‘ﬁlm surface density’’ (FSD) of the ﬁlm
layer. At an incidence angle of 01, the FSD can be expressed as
follows:
FSD¼ n1n0
n1þn0
ð4Þ
W. Momose et al. / Results in Pharma Sciences 2 (2012) 29–3732Furthermore, R1 of an uncoated tablet was deﬁned as the
‘‘uncoated surface density’’ (USD).
In Fig. 4(a), scaled waveforms are superimposed so that the
peak value of the main pulse reference signal eref(t) is equal to
that of the measured signal esam(t). By assuming that the coating
material of the ﬁlm-coated tablet has no dispersion in the
terahertz domain, the different waveforms of these signals
(Fig. 4b) can be used to selectively extract the reﬂection signal
from the inside of the ﬁlm-coated tablet. The fall at t1 in the
horizontal axis of Fig. 4(b) is a signal reﬂected from the boundary
between the ﬁlm-coated layer and the tablet core of a ﬁlm-coated-0.1
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Fig. 4. (a) Scaled reference terahertz signal (green signal) and measured signal
from the tablet (blue signal). (b) Difference between scaled reference and
measured signals. (For interpretation of the references to color in this ﬁgure
legend, the reader is referred to the web version of this article.)
Table 3
Surface density and interface density difference of the manufactured tablets.
Batch X6-1 X6-2 X6-3
Manufacturing scale Pilot Pilot Pilot
Size of spray mist Standard Large Small
Rate of crack initiation (%) 0 80 0
FSD and USD (%) T1 22.58 21.27 21.81
T2 22.25 21.11 21.05
T3 21.41 20.86 20.89
T4 20.74 19.70 21.27
T5 21.82 19.92 20.78
T6 21.11 20.60 21.82
T7 21.94 20.37 21.50
T8 20.90 18.24 21.24
T9 21.39 20.19 22.04
T10 22.41 19.51 22.09
T11 22.05 18.25 20.49
Mean 21.7 20.0 21.4
SD 0.6 1.1 0.5
t-test – 1.50E04 1.96E01
IDD (%) T1 6.27 6.63 7.31
T2 7.05 7.47 7.73
T3 6.74 7.38 7.69
T4 7.04 6.36 6.97
T5 6.86 7.19 6.75
T6 7.74 6.49 6.89
T7 7.07 7.02 7.11
T8 6.66 6.07 7.66
T9 6.77 6.69 7.06
T10 7.88 6.63 8.19
T11 7.92 5.36 6.69
Mean 7.1 6.7 7.3
SD 0.5 0.6 0.5
Different spray mists were created by changing atomizer air volume and airﬂow pattetablet. Fresnel’s formula suggests that the amplitude I2 at t1
changes with the refractive index difference (density difference)
at the boundary between the ﬁlm-coated layer and the tablet
core. Here, using I0 obtained by reference measurement, the
interface density difference (IDD) is deﬁned as
IDD¼ I2=I0 ð5Þ
The polarity of IDD is determined from the relative magnitude
of the refractive index n1 of the ﬁlm-coated layer and the
refractive index n2 of the tablet core, and is expressed as follows:
IDD40 ðn1on2Þ
IDDo0 ðn14n2Þ ð6Þ
IDD can thus be considered an index to express the sharpness
of the boundary between the ﬁlm-coated layer and the
tablet core.
In addition, the time lag Dt1(¼t1–t0) in Fig. 4 changes depend-
ing on the thickness of the ﬁlm-coated layer. When the terahertz
wave is perpendicularly incident on the ﬁlm-coated tablet, the
ﬁlm thickness L of the ﬁlm-coated layer can be expressed by using
the speed of light, c as follows:
L¼ cDt1
2n1
ð7Þ
3. Results and discussion
From each batch of ﬁlm-coated tablets, 11 samples for the
reﬂection measurement using terahertz waves were chosen for
FSD and IDD analysis. At the same time, reﬂection measurement
of three X6 (uncoated tablet A) samples and three Y9 (uncoated
tablet B) ones was conducted. Also, USD analysis was conducted
for X6 and Y9. Mean values and standard deviations (SD) of FSDZ6-1 Y9-1 W9-1 X6 Y9
Commercial Pilot Commercial – –
Standard Standard Standard – –
40 0 40 – –
17.92 20.28 19.04 17.60 17.34
19.00 20.28 19.08 17.73 17.48
19.35 20.97 20.11 16.85 17.96
19.11 20.80 19.72 – –
21.45 21.91 19.13 – –
20.07 20.15 19.12 – –
20.86 22.88 19.44 – –
20.67 21.51 20.03 – –
20.48 21.22 18.27 – –
20.96 20.75 18.96 – –
22.32 21.56 18.79 – –
20.2 21.1 19.3 17.4 17.6
1.3 0.8 0.6 0.5 0.3
2.15E03 8.01E02 4.31E09 – –
6.21 7.31 6.50 – –
6.22 7.31 6.93 – –
6.36 7.24 6.64 – –
6.23 7.51 6.55 – –
6.98 7.86 6.70 – –
6.96 8.01 6.17 – –
6.62 8.59 6.76 – –
6.99 7.65 6.71 – –
6.75 7.43 6.89 – –
7.13 7.30 6.13 – –
7.49 7.24 6.48 – –
6.7 7.6 6.6 – –
0.4 0.4 0.3 – –
rn.
W. Momose et al. / Results in Pharma Sciences 2 (2012) 29–37 33and IDD are shown in Table 3. Of interest, the mean value of FSD
for the batches of ﬁlm-coated tablets in which cracks were noted
in the ﬁlm-coated layer (X6-2, Z6-1, W9-1) was smaller than that
for the batches of ﬁlm-coated tablets in which cracks were not
noted (X6-1, X6-3, Y9-1). The measurement frequency range of
this system is up to 3 THz and the dynamic range is more than
50 dB. Considering the measurement frequency range and the
dynamic range of this system, 1% difference of FSD is signiﬁcant.
Additionally, the results of the two-sided, two-sample t-distribu-
tion tests using the mean value of the parent population were
shown in Table 3. One of the two samples was always from the
X6-1 batch, and its signiﬁcance was veriﬁed against the other
batches. The signiﬁcance level was assumed to be 5%. FSD valuesTable 4
FCSI values of the batches calculated using Eq. (7) before degradation tests.
X6-1 X6-2 X6-3 Z6-1 Y9-1 W9-1
T1 141.6 141.0 159.4 111.3 148.2 123.7
T2 156.8 157.6 162.7 118.2 148.2 132.3
T3 144.3 153.9 160.6 123.1 151.9 133.6
T4 146.1 125.4 148.3 119.1 156.1 129.1
T5 149.8 143.3 140.3 149.7 172.1 128.1
T6 163.3 133.7 150.2 139.7 161.4 117.9
T7 155.2 143.0 152.9 138.0 196.6 131.4
T8 139.3 110.7 162.7 144.5 164.7 134.4
T9 144.8 135.0 155.6 138.2 157.6 126.0
T10 176.7 129.3 180.8 149.6 151.5 116.2
T11 174.6 97.8 137.0 167.1 156.2 121.7
Mean 153.9 133.7 155.5 136.2 160.4 126.8
SD 12.9 17.7 12.0 16.8 14.0 6.2
t-test – 6.2E-03 7.6E-01 1.2E-02 2.7E-01 4.0E-06
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Fig. 5. Histogram of FCSI for 11 ﬁlm-coated tablets: (a) batch X6-1, (b) batchfor batches of ﬁlm-coated tablets in which cracks were not noted
(X6-1, X6-3, Y9-1) were conﬁrmed to be different from those
for them of in which cracks were noted in the ﬁlm-coated layer
(X6-2, Z6-1, W9-1) statistically by t-test.
The batches with small mean FSD included the batch (X6-2) in
which the spray mist diameter in the coating process was larger
than the standard value and those batches (Z6-1, W9-1) where
the scale differed from the standard. As such, we may assume that
a relatively large spray mist diameter tends to generate a low-
density ﬁlm-coated layer. From the viewpoint of crack initiation,
low FSD suggests relatively little tensile strength in the ﬁlm-
coated layer, and consequently, an increased probability that the
layer will be disrupted due to expansion of the tablet core. As
such, having a low FSD is believed to be a condition contributing
to crack induction in the ﬁlm-coated layer.
As shown in Table 3, the highest mean USD value for uncoated
tablets was 17.6% (Y9), which is more than 1.7% less than the
lowest mean value of FSD (19.3%, W9-1). On examining the IDD
values, the IDD in the batches of ﬁlm-coated tablets in which
cracks were noted in the ﬁlm-coated layer was at least 0.4% less
than the value in the batch without cracks. On comparing coating
processes, the level of IDD was relatively low in the X6-2 batch
(6.7%70.6%), which had a larger coating mist diameter than the
standard value, and the Z6-1 (6.7%70.4%) and W9-1 batches
(6.6%70.3%), where the production scale differed from that for
the X6-1 batch (7.1%70.5%). Of note, all IDD analysis results
were negative because, as shown in the relation of Eq. (5), the FSD
of the ﬁlm-coated layer was higher than the USD of the tablet core
in all batches of ﬁlm-coated tablets. We may observe such a trend
of having small absolute values of IDD in any batch where we ﬁnd
cracks in the ﬁlm-coated layer.0
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Table 5
Crack initiation results during degradation tests (80 min at 60 1C).
Group Sample name FCSI Results Ratio (%)
Crack initiation Time (min)
Small FCSI Z6-1_02 118 Yes 20 75
Z6-1_05 119 Yes 20
W9-1_15 122 No –
Z6-1_03 123 Yes 20
W9-1_02 124 Yes 20
X6-2_07 125 No –
W9-1_13 126 Yes 20
W9-1_06 128 Yes 30
Middle FCSI W9-1_11 134 Yes 20 25
Z6-1_07 140 Yes 30
X6-3_07 140 No –
X6-1_02 142 No –
X6-1_04 144 No –
X6-1_11 145 No –
X6-1_05 146 No –
X6-3_06 148 No –
Large FCSI Y9-1_12 158 No – 0
X6-3_01 159 No –
X6-3_04 161 No –
X6-3_11 163 No –
X6-3_02 163 No –
X6-1_07 163 No –
Y9-1_11 165 No –
Z6-1_15 167 No –
W. Momose et al. / Results in Pharma Sciences 2 (2012) 29–3734IDD can be viewed as an index representing the interfacial
sharpness between the ﬁlm-coated layer and tablet core. Under
the coating processes adopted in this study, both spray mist
diameters and production scales varied. As such, depending on
the process conditions, different spray mist conditions may have
been applied to the uncoated tablet surface during coating,
thereby creating different interface conditions between the ﬁlm-
coated layer and tablet core. These varying conditions may thus
create a difference in sharpness at the interface between the ﬁlm-
coated layer and tablet core, producing different IDD values for
different batches. Ultimately, a higher absolute value of IDD
indicates a clearer difference between the coated layer and tablet
core. If sharpness between ﬁlm coated layer and tablet core is
unclear, it is difﬁcult for ﬁlm coated materials to be extended
smoothly on swelling tablets. This is a reason why small absolute
values of IDD in any batch where we ﬁnd cracks in the ﬁlm-
coated layer.
3.1. Nondestructive prediction of cracks in the ﬁlm-coated layer
We then examined techniques for predicting crack initiation in
the ﬁlm-coated layer using the analysis parameters discussed
earlier in the manuscript. We conﬁrmed above that FSD and IDD
analyzed by terahertz waves tended to be low in batches of ﬁlm-
coated tablets in which a crack occurred in the ﬁlm-coated layer
under high-temperature conditions. This ﬁnding therefore sug-
gested that low density of the ﬁlm-coated layer and indistinctness
of the boundary surface between the ﬁlm-coated layer and tablet
core were related to crack initiation in the ﬁlm-coated layer under
high-temperature conditions. Therefore, the index obtained by
multiplying the FSD and IDD could potentially be useful in
predicting crack initiation in the ﬁlm-coated layer. The ﬁlm-
coating strength index (FCSI) was therefore deﬁned to verify its
relationship with crack initiation as follows:
FCSI¼ 9FSD IDD9 ð8Þ
A smaller FCSI value indicates an elevated risk of crack
initiation. Table 4 shows the calculated values of FCSI for the
measured ﬁlm-coated tablets and the results of the two-sided,
two-sample t-distribution tests using the mean value of the
parent population. These measurements were conducted before
degradation tests. One of the two samples was always from the
X6-1 batch, and its signiﬁcance was veriﬁed against the other
batches. The dispersion ratio of the samples was evaluated by
using an F-test and an appropriate t-test method was selected.
The signiﬁcance level was assumed to be 5%.Fig. 6. Appearance of ﬁlm-coated tablets in batch W9-1Table 4 shows that FCSIwas particularly low in the X6-2 batch,
which had the largest RCI value of all batches examined; in
addition, FCSI was also low in batches Z6-1 and W9-1, in which
cracks were noted. The p-value (two-sided probability) of the
t distribution test in all the batches with cracks in the ﬁlm-coated
layer is sufﬁciently smaller than the signiﬁcance level, suggesting
a large statistical difference. However, there should be no statis-
tical difference in the batches without cracks where the p-value is
higher than the signiﬁcance level. Taken together, these results
indicate a statistically signiﬁcant difference in FCSI between
batches with and without cracks in the ﬁlm-coated layer.
RCIs of batches X6-2, Z6-1, and W9-1, which all showed cracks
in the ﬁlm-coated layer, were 80%, 40%, and 40%, respectively,
indicating that some tablets in these batches experienced no
cracks even under high-temperature conditions. A histogram of
FCSIs from Table 4 was compiled to clarify the relationship
between FCSI distribution and the RCI of each batch (Fig. 5). FCSIsduring and after degradation test (80 min at 70 1C).
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c, and e), while those with an RCI of 40 are distributed below 130
(Fig. 5b, d, and f). This histogram suggests that the values of FCSI
below 130 are due to the ﬁlm-coated tablets with cracks.3.2. Veriﬁcation of correlation between FCSI and the crack initiation
Using ﬁlm-coated tablets from batch W9-1 with RCI 40%,
accelerated degradation tests were conducted to verify the
correlation between FCSI values and crack initiation of the ﬁlm-
coated layer. From batch W9-1, the ﬁlm-coated tablets with the
largest and smallest FCSI values were stored in a drying oven
(DO-450VC; AS ONE, Osaka, Japan) for 80 min at 70 1C. The
appearance of the ﬁlm-coated tablets was visually inspected by
opening the door of the drying oven approximately every 10 min.Fig. 8. Crack initiation results during degradation tests for ﬁlm-
Fig. 7. Relationship between FCSI values and crack initiation.The open portion of the drying oven is covered with a transparent
plastic ﬁlm to prevent heat from escaping if the door is left open
at the time of observation.
Fig. 6 shows the ﬁlm-coated tablets during and after the
accelerated degradation test (80 min). While a crack formed in the
ﬁlm-coated tablets with the lowest FCSI in batch W9-1 at 60 min
after starting the test, no cracks were found in the tablets with the
highest FCSI. The crack in the ﬁlm-coated layer is clearly recogniz-
able in the photographs in Fig. 6 taken during the test
(0–80 min). This result shows that crack appearance was properly
predicted based solely on FCSI values in the batches of ﬁlm-coated
tablets—even in batches such as W9-1, which included tablets with
and without cracks in accelerated degradation tests. For pharma-
ceutical companies, tablets must be developed while taking into
account degradation risks under a range of conditions. If appropriate
nondestructive tools such as our novel tool described here cannot be
used, such risks will have to be evaluated in degradation tests,
which are costly in terms of development time and ﬁnancial strain
are increased. Our case studies conducted in this paper may be a
special example, because we used the unique formulation with
swelling materials in non-coated tablets. However, there are lots of
merits for terahertz waves used for analyses of pharmaceutical
products. One of them is to analyze a coated thickness with a special
measurement principle. Our case studies are also one of the good
examples using terahertz waves for analyses of pharmaceutical
products.
3.3. Veriﬁcation of accuracy of using FCSI in nondestructive
prediction of crack initiation
Three groups of eight tablets each with different FCSI values
were selected from different batches. The ﬁrst group was
arranged to have relatively small FCSI values, ranging from 118
to 128, the second group to have middle FCSI values, ranging from
134 to 148, and the third group to have large FCSI values, rangingcoated tablets with different FCSI values (80 min at 60 1C).
Fig. 9. Crack initiation results after degradation tests for ﬁlm-coated tablets with different FCSI values (80 min at 60 1C).
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(DO-450VC; AS ONE) for 80 min at 60 1C (reduced from 70 1C
because milder conditions were believed to be better for detect-
ing differences in sample appearance).
Samples used in the present studies and the results of crack
initiation after degradation tests are listed in Table 5. In addition,
Fig. 7 shows the relationship between FCSI and crack initiation.
Both highlight the good correlation between FCSI values and crack
initiation. Tablets with relatively small FCSI exhibited a dramati-
cally increased ratio of crack initiation compared with tablets
with relatively large FCSI. These results support the notion of
using FCSI for nondestructive prediction of crack initiation.
Figs. 8 and 9 show the ﬁlm-coated tablets during and after the
accelerated degradation test (80 min).4. Conclusion
This novel study reported a new nondestructive technique
using terahertz waves to analyze the coating characteristics ofdrug tablets. Using such a method, the structure and physical
characteristics, which are typically difﬁcult to analyze, can be
analyzed in the depth dimension of the tablet. We demonstrated
our ability to determine the density of the ﬁlm-coated layer over
the tablet core, which has thermally expansive characteristics, as
well as the information on the interface between the ﬁlm-coated
layer and the tablet core. In addition, FCSI was newly deﬁned
using FSD and IDD values obtained via nondestructive measure-
ment of terahertz waves and presented as a promising index for
determining risk of crack initiation in ﬁlm-coated tablets. Apply-
ing these analytical methods using terahertz waves to process
development and scale-up and scale-down experiments, which
will become increasingly complex in the future, is expected to
substantially improve product quality and development efﬁ-
ciency. Effective use of our novel approach will reduce develop-
ment time and ﬁnancial cost in terms of effectively determining
ﬁlm coating process parameters without degradation tests. In this
paper, we demonstrated nondestructive prediction of cracks in
the ﬁlm-coated layer on a certain swelling tablet. By putting more
evaluation with some combination of ﬁlm-coating materials,
W. Momose et al. / Results in Pharma Sciences 2 (2012) 29–37 37swelling tablets and process parameters based on the design of
experiments into execution, a typical range of FCSI values from a
single batch can be provided for a representative sample of a
batch that will crack and other that will not crack. Additional case
studies using FSD, IDD and FSCI will be necessary for further
discussions about availability of this technology to other tablets.
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